Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!
Compound changning mixture
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
The technology of Changning mixture and compound formula is applied in the field of Chinese patent medicine preparations, which can solve the problems of affecting use, easy recurrence of the disease, and large side effects of drugs, and achieves the effects of no toxic side effects, good compliance, and low cost of raw materials.
Inactive Publication Date: 2011-01-12
刘爱玲
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, the above-mentioned drugs can cause liver and kidney damage, bone marrow suppression, skin rash, and long-term use of hormones can cause osteoporosis, secondary hypertension, diabetes, superinfection, mental changes, electrolyte disturbances, and many other adverse reactions. Drug side effects Large, prone to recurrence of the disease, seriously affecting their use
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0008] This embodiment is prepared by using Astragalus, Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes grandiflora Radix, Radix Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Sinensis as raw materials in this embodiment. The components (weight %) are astragalus 16, Atractylodes macrocephala 8, coptis 6, Patrinia 16, coix seed 20, bellflower 11, madder 10, pangolin 9 and angelica 4. Take the above-mentioned nine kinds of raw materials with a total weight of 54 kg, select and wash them, soak the medicine in water for 20 minutes and then decompose. Add 12000ml of wa...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The present invention relates to the art of drug formulation, in particular to a Compound Chang-Ning Mixture, which is made from milk veteh, largehead atractylode, coptis root, Patrinia villosa, coix seed, ballonflower root, india madder root, pangolin and angelica. Milk veteh, largehead atractylode, coptis root, Patrinia villosa, coix seed, ballonflower root, india madder root, pangolin and angelica are cleaned and soaked with water, then decocted and filtered to get the filtrate, finally disinfected and refined to get the mixture. The technical characteristic is that the weight portions of the raw materials are as follows: 12 to 22 percent of milk veteh, 8 to 10 percent of largehead atractylode, 4 to 6 percent of coptis root, 12 to 16 percent of Patrinia villosa, 12 to 23 percent of coix seed, 10 to 14 percent of ballonflower root, 10 to 12 percent of india madder root, 8 to 10 percent of pangolin and 4 to 6 percent of angelica, and the total percent of the raw materials is 100 percent. The Compound Chang-Ning Mixture has the characters of low cost of raw materials, good compliance, and no toxic side effect, thus improving the body immunity and curing ulcerative clotis effectively.
Description
technical field [0001] The invention relates to a Chinese patent medicine preparation, in particular to a compound Changning mixture for treating ulcerative colitis. Background technique [0002] Ulcerative colitis is an autoimmune disease. It is an inflammatory disease of the colon whose etiology is not yet fully understood. It may be related to infection, immunity, genetics, mental, neurological factors, and diet. It is often a chronic process with a course of several years. From one year to more than ten years, there are often alternations of attack periods and remission periods. Severe cases may have complications such as gastrointestinal bleeding, intestinal perforation, and cancer. Modern medicine mainly adopts drugs such as aminosalicylic acids, adrenal cortex hormones and immunosuppressants. However, the above-mentioned drugs can cause liver and kidney damage, bone marrow suppression, skin rash, and long-term use of hormones can cause osteoporosis, secondary hypert...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.